Mesenchymal stromal cell–mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma
Discussion The study supports the use of DPSC as a neuroprotective cellular therapy in retinal degenerative disease such as glaucoma.
Source: Cytotherapy - Category: Cytology Source Type: research
More News: Blindness | Brain | Cytology | Eyes | Ganglions | Glaucoma | Neurology | Opthalmology | Stem Cell Therapy | Stem Cells | Study | Transplants